SEC Tracker
Get the app

Transcode Therapeutics RNAZ

TransCode Therapeutics Announces 1-for-33 Reverse Stock Split

Form
8-K
Filed
Period
Importance
Notable
Document
8-K
Exhibit 99.1
Press release
  • Changes shareholder rights (3.03)
  • Amends its charter or bylaws (5.03)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Transcode Therapeutics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Adial Pharmaceuticals ADIL public float $6M, Jun 30, 2025
  2. AIM ImmunoTech AIM public float $6M, Jun 30, 2025
  3. Vyome Holdings HIND public float $6M, Jun 30, 2025
  4. Biomerica BMRA public float $7M, Nov 28, 2025
  5. Protagenic Therapeutics, Inc.\new PTIX public float $7M, Sep 30, 2025